S&P 500 7,674 -1.43% Nasdaq 26,180 -2.05% Dow Jones 53,277 -0.85% FTSE 100 10,817 +0.62% DAX 26,137 -1.15% Nikkei 225 66,016 -4.63% Hang Seng 26,009 +3.55% WTI Crude 87.06 +2.50% Gold 4,681 +7.21% US 10-Year Treasury Yield 4.738 +0.30% S&P 500 7,674 -1.43% Nasdaq 26,180 -2.05% Dow Jones 53,277 -0.85% FTSE 100 10,817 +0.62% DAX 26,137 -1.15% Nikkei 225 66,016 -4.63% Hang Seng 26,009 +3.55% WTI Crude 87.06 +2.50% Gold 4,681 +7.21% US 10-Year Treasury Yield 4.738 +0.30%

LATEST

Retirees can supplement their Social Security with two top dividend stocks●Oracle vs. Amazon: Which Is the Better AI Cloud Stock to Own for the Next 5 Years?●Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?●Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?●Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?●Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?●FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?●AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?●Retirees can supplement their Social Security with two top dividend stocks●Oracle vs. Amazon: Which Is the Better AI Cloud Stock to Own for the Next 5 Years?●Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?●Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?●Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?●Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?●FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?●AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?●

Front Page

Japan Borrowing Costs Reach 1996 Highs: Will the Weak Yen Hurt Bitcoin?

Yahoo Finance · 1h ago · 🇯🇵 Japan

Japan Borrowing Costs Reach 1996 Highs: Will the Weak Yen Hurt Bitcoin?

Read the full story at Yahoo Finance →

More Front Page

Oracle vs. Amazon: Which Is the Better AI Cloud Stock to Own for the Next 5 Years?

Yahoo Finance · 37m ago

Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?

Yahoo Finance · 52m ago

Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?

Yahoo Finance · 56m ago

Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?

Yahoo Finance · 1h ago